PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 112 filers reported holding PULMONX CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,890,619 | -52.8% | 376,633 | -40.1% | 0.00% | -50.0% |
| Q2 2023 | $8,247,121 | +510874.0% | 629,071 | +335.6% | 0.00% | +300.0% |
| Q1 2023 | $1,614 | +190.8% | 144,400 | +119.5% | 0.00% | – |
| Q4 2022 | $555 | -100.0% | 65,780 | -42.2% | 0.00% | -100.0% |
| Q2 2022 | $1,675,000 | -28.0% | 113,823 | +21.5% | 0.00% | -50.0% |
| Q1 2022 | $2,325,000 | +35.8% | 93,680 | +75.4% | 0.00% | – |
| Q4 2021 | $1,712,000 | +288.2% | 53,407 | +434.1% | 0.00% | – |
| Q2 2021 | $441,000 | -97.2% | 10,000 | -97.1% | 0.00% | -100.0% |
| Q1 2021 | $15,540,000 | – | 339,742 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $43,898,000 | 8.08% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 93,831 | $4,140,000 | 8.00% |
| Miura Global Management | 570,000 | $25,148,000 | 4.59% |
| Iron Triangle Partners LP | 550,000 | $24,266,000 | 2.50% |
| Beck Bode, LLC | 116,442 | $5,137,000 | 1.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,800,887 | $79,455,000 | 1.41% |
| Affinity Asset Advisors, LLC | 60,000 | $2,647,000 | 0.95% |
| PURA VIDA INVESTMENTS, LLC | 595,231 | $26,262,000 | 0.82% |
| RTW INVESTMENTS, LP | 1,129,600 | $49,838,000 | 0.75% |
| ABG Innovation Capital Partners III GP Ltd | 4,521 | $199,000 | 0.67% |